Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

The Use of Validated Measures of Alcohol Intake to Measure the Impact of Moderate Alcohol Consumption on Hepatic Fibrogenesis in Individuals Infected With Hepatitis C

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00205075

Enrollment

Registered

2005-09-20

Start date

2004-08-31

Completion date

2008-06-30

Last updated

2015-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Fibrogenesis, Hepatitis C

Brief summary

The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately

Exclusion criteria

* HIV co-infection * Treated within the past 6 months * History (hx) of other liver disease * Alcohol use greater than 30 g/day or history of binge drinking in the last year * Decompensated liver disease

Countries

United States

Outcome results